Sernova (TSE:SVA) Posts Quarterly Earnings Results

Sernova (TSE:SVA) issued its quarterly earnings data on Thursday. The company reported C($0.01) earnings per share for the quarter, FiscalAI reports.

Sernova Stock Down 3.6%

SVA opened at C$0.14 on Friday. The firm’s 50 day simple moving average is C$0.12 and its two-hundred day simple moving average is C$0.14. The company has a market capitalization of C$50.98 million, a PE ratio of -3.38 and a beta of -0.43. Sernova has a 1-year low of C$0.10 and a 1-year high of C$0.20. The company has a current ratio of 0.03, a quick ratio of 18.11 and a debt-to-equity ratio of -21.98.

About Sernova

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.